BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 12391265)

  • 1. Modulation of the hydrophobic domain of polymyxin B nonapeptide: effect on outer-membrane permeabilization and lipopolysaccharide neutralization.
    Tsubery H; Ofek I; Cohen S; Eisenstein M; Fridkin M
    Mol Pharmacol; 2002 Nov; 62(5):1036-42. PubMed ID: 12391265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-function studies of polymyxin B nonapeptide: implications to sensitization of gram-negative bacteria.
    Tsubery H; Ofek I; Cohen S; Fridkin M
    J Med Chem; 2000 Aug; 43(16):3085-92. PubMed ID: 10956216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The outer membrane permeability-increasing action of linear analogues of polymyxin B nonapeptide.
    Vaara M
    Drugs Exp Clin Res; 1991; 17(9):437-43. PubMed ID: 1822436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-terminal modifications of Polymyxin B nonapeptide and their effect on antibacterial activity.
    Tsubery H; Ofek I; Cohen S; Fridkin M
    Peptides; 2001 Oct; 22(10):1675-81. PubMed ID: 11587796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The functional association of polymyxin B with bacterial lipopolysaccharide is stereospecific: studies on polymyxin B nonapeptide.
    Tsubery H; Ofek I; Cohen S; Fridkin M
    Biochemistry; 2000 Oct; 39(39):11837-44. PubMed ID: 11009595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-activity relationships of bacterial outer-membrane permeabilizers based on polymyxin B heptapeptides.
    Urakawa H; Yamada K; Komagoe K; Ando S; Oku H; Katsu T; Matsuo I
    Bioorg Med Chem Lett; 2010 Mar; 20(5):1771-5. PubMed ID: 20138759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of the cell envelope in the antibacterial activities of polymyxin B and polymyxin B nonapeptide against Escherichia coli.
    Sahalan AZ; Dixon RA
    Int J Antimicrob Agents; 2008 Mar; 31(3):224-7. PubMed ID: 18083010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neopeptide antibiotics that function as opsonins and membrane-permeabilizing agents for gram-negative bacteria.
    Tsubery H; Yaakov H; Cohen S; Giterman T; Matityahou A; Fridkin M; Ofek I
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3122-8. PubMed ID: 16048913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymyxin B octapeptide and polymyxin B heptapeptide are potent outer membrane permeability-increasing agents.
    Kimura Y; Matsunaga H; Vaara M
    J Antibiot (Tokyo); 1992 May; 45(5):742-9. PubMed ID: 1624376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymyxin B and polymyxin B nonapeptide alter cytoplasmic membrane permeability in Escherichia coli.
    Dixon RA; Chopra I
    J Antimicrob Chemother; 1986 Nov; 18(5):557-63. PubMed ID: 3027012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of polymyxin B nonapeptide on daptomycin permeability and cell surface properties in Pseudomonas aeruginosa, Escherichia coli, and Pasteurella multocida.
    Morris CM; George A; Wilson WW; Champlin FR
    J Antibiot (Tokyo); 1995 Jan; 48(1):67-72. PubMed ID: 7868392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of small cationic leukocyte peptides (defensins) on the permeability barrier of the outer membrane.
    Viljanen P; Koski P; Vaara M
    Infect Immun; 1988 Sep; 56(9):2324-9. PubMed ID: 3137167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contribution of each amino acid residue in polymyxin B(3) to antimicrobial and lipopolysaccharide binding activity.
    Kanazawa K; Sato Y; Ohki K; Okimura K; Uchida Y; Shindo M; Sakura N
    Chem Pharm Bull (Tokyo); 2009 Mar; 57(3):240-4. PubMed ID: 19252313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outer Membrane Interaction Kinetics of New Polymyxin B Analogs in Gram-Negative Bacilli.
    Akhoundsadegh N; Belanger CR; Hancock REW
    Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31332075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding of polymyxin B nonapeptide to gram-negative bacteria.
    Vaara M; Viljanen P
    Antimicrob Agents Chemother; 1985 Apr; 27(4):548-54. PubMed ID: 2988430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Membrane-disorganizing property of polymyxin B nonapeptide.
    Lam C; Hildebrandt J; Schütze E; Wenzel AF
    J Antimicrob Chemother; 1986 Jul; 18(1):9-15. PubMed ID: 3019982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expansion of antibacterial spectrum of xanthorrhizol against Gram-negatives in combination with PMBN and food-grade antimicrobials.
    Kim MS; Kim HR; Kim H; Choi SK; Kim CH; Hwang JK; Park SH
    J Microbiol; 2019 May; 57(5):405-412. PubMed ID: 30796747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of polymyxin B nonapeptide on Aeromonas salmonicida.
    McCashion RN; Lynch WH
    Antimicrob Agents Chemother; 1987 Sep; 31(9):1414-9. PubMed ID: 2823698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of polymyxin B nonapeptide (PMBN) on transformation.
    Viljanen P
    Biochem Biophys Res Commun; 1987 Mar; 143(3):923-7. PubMed ID: 3032189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The outer membrane permeability-increasing action of deacylpolymyxins.
    Viljanen P; Matsunaga H; Kimura Y; Vaara M
    J Antibiot (Tokyo); 1991 May; 44(5):517-23. PubMed ID: 1648055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.